BSECompany Update3d ago · 22 Sept 2026, 05:51 pm
Pursuant to the Regulation 30read with Schedule III of SEBI(LODR) Regulations, 2015, we wish to inform you that Ishita Drugs and Industries Limited has entred into loan agreement with HDFC Bank Limited.
Ishita Drugs & Industries Ltd · 524400
✦ AI SummaryDebt Restruc.
Ishita Drugs & Industries Ltd has entered into a loan agreement with HDFC Bank Limited to raise funds for financing the upgradation project for its manufacturing facility at Sanand, Dist. Ahmedabad, Gujarat.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ishita Drugs & Industries Ltd - 524400 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Availing Credit Facilities From Bank
Attachments (1)
📄pdf
Download →
686b4984-050d-4730-b864-85f8fdc15812.pdf
View document text
lsHITA DRUGS & INDUSTRIES LTD.
Conp. On: 401, 3rd E)re 11, Opp. Parimal Garden, C. G. Road. Ahmedahad-380006.
I`e8d. Once & Factory : 179/I. \fasna-I)fava. Thl. Sanand, Dist. : Ahlmedabad.
E-mall : ishitadnles@mall.com I ]nfo®ishltadrugs.com I URL : www.ishitadruf!s.com
Phone : +9 I 72269956 I 3/ 14/ I 5 +9179 cO2 3839
Date: 22,09.2026
The Department of Corporate Services,
BSE Limited.
Floor No. 25, Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400001.
Scrin Code: 524400
Dear Sir/Madam,
Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India
fListting Ob]iE!atious and Disclosure Reauirements` Regulations. 2015 -Availing Credit
Facilities from Bank
Pursuant to the Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and
Disclosure Requirements) Regulation, 2015, we wish to inform you that Ishita Drugs and
Industries Limited("Company") has entered into loan agreement with HDFC Bank Limited
(Thderl.
Further, the details of loan agreement as required under the Listing Regulations read with the
SEBI Master Circular No. HO/49/14/14C7)2025{FD-POD2/I/3762/2026 dated 30th January,
2026 are enclosed herewith as "Annexure A."
The said disclosure is also being uploaded on the Company's website www.ishitadrups,c.om
Please take the above details on your reco'rds.
Thanking You.
For, Ishita Drugs and Industries Limited
]agdish Agrawal
Managing Director
I)IN: 01031687
-Our 6asi¢ fui8S in the Savi¢¢ Of hunandy ®Liord6wide n
CIN No. L24231 GJ1992PLC017054
D a 8 D`u-N€ Number -65018ro359
lsHITA DRUGS & INDUSTRIES LTD.
Corfb On: 401, 3rd i)re 11, Opp. Parimal Garden, C. G. Road. Ahmedabad-380006.
Reed. Oflce & I:actory : 179/I, Vlsna-I)rave. fal. Sanand, Dist, : Ahmedabad.
E-mall : istihadrues@mail.com I lnfo@ishitadn.£s.com I URL : www.ishitadrues.com
Phone : +9 I 722699S61 3/ 14/ I 5 I +9179 4002 3839
` AnnexL]re -A
The details as required under RenJlation 30 - of SEB] rListim! Oblimatfons and Disclosure
Reciuirementsl Regulations 2015 read with the SEBI Master circular No.
HO/49/14/14r712025-CFD-POD2/I/3762/2026 dated 30th Tanuarv. 2026:
Sr.No. Particulars Details
1. Name(s) of parties with whom the agreement is Loan Agreement between Ishita Drugs and
entered; Industries Limited ("Company'') and HDFC Bank
Limited ("Lender'')
2. Purpose of entering into the agreement To raise funds for financing the upgradation project
(to comply with the Revised Schedule M) for our
manufacturing facility at Sanand, Dist. Ahmedabad,
Gujarat
3. Size of agreement Rs. 11,75,00,000/- (Rupees Eleven Crore Seventy-
Five Lakh Only)
4. Shareholding, if any, in the entity with whom the NIL
agreement is executed
5. Significant terms of the agreement (in brief)
special rights like right to appoint directors, first There are no special rights given to HDFC Bank
right to share subscription in case of issuance of Limited
shares, right to restrict any change in capital
structure etc,
6 Whether, the said parties are related to NO
promoter/promoter group/ group companies in
any manner. If yes, nature of relationship
7. Whether the transaction would fall NO
within related party transactions? If yes, whether
the same is done at "arm's length"
8. In case of issuance of shares to the parties, details NO
of issue price, class of shares issued
•our E]asi¢ drigs in chc Sonhee Of hrmanrty ¢iiorddwidc
CIN No. L24231GJ1992PLC017054
D 8 a D-U-N€ Number -65rol8-0359
ISHITA DRUGS & INDUSTRIES LTD.
Carp. Off.: 401, 3rd Eye 11, Opp. Parimal Garden, C. G. Road, Ahmedabad-380006.
Regd. Office & Factory : 179/I, VasnaL-lyava, Tal. Sanand, Dist. : Ahmedabad.
E-mall : ish ail.com I lnfo®lshhadrufs.com I URL : www.ishitadrues.cc>m
Phone : +91 7226995613/ 14/ 15 I +9179 4002 3839
9. In case of loan agreements, details of lender, • Lender: HDFC BankLimited
riature of the loan, total amount of loan granted, • Nature of Loan: Term Loan & Working
total amount outstanding, `date of execution of the Capital Facility
loan agreement / sanction letter, details of the • Amount of Loam Rs. 9,75,00,000/-(Rupees
security provided to the lenders for such loan Nine Crore Seventy-Five Lakh Only) Term
Loan and Rs. 2,00,00,000/- (Rupees Two
Crore Only) Working Capital Facility
• Amountoutstanding: NIL
• DateofExecution: 22.09.2026
• -Details of the Security Provided: First
charge on the immovable and movable assets
of the Company situated at SURVEY NO.
179/1, VILLAGE VASNA IYAVA, TA
SANAND, SANAND VIRAMGAM HIGHWAY,
382170
10. Any other disclosures related to such agreements, Not Applicable
viz., details of nominee on the board of directors
of the listed entity, potential conflict of interest
arising out of such agreements, etc
11. In case of termination or amendment of Not Applicable
agreement, listed entity shall disclose additional
details to the stock exchange(s): i.name of parties
to the agreement; ii. nature of the agreement;
iii. date of execution of the agreement; iv. details
of amendment and impact thereof or reasons of
termination and impact thereof
•Oii;r6asiedrugsinthesewiceofhunairty.LiorttiLiiide
CIN No. L24231GJ1992PLC017054
D a a D-U-N-S Number -65J)18-0359